yihR Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Context of yihR Antibody

The term "yihR Antibody" refers to an antibody targeting the yihR protein, which is encoded by the yihR gene. While the yihR gene is recognized in bacterial genomics (notably in Escherichia coli), there is no direct reference to a commercially available or research-focused "yihR Antibody" in the provided sources. Antibodies are typically developed against well-characterized antigens, such as viral proteins or cancer biomarkers, to enable applications like diagnostics, therapeutics, or research tools. The absence of explicit mentions in the search results suggests that yihR is either a less-studied target or that nomenclature differences exist (e.g., alternative gene/protein names).

Research Findings and Data Gaps

A review of antibody databases, therapeutic pipelines, and research publications within the provided materials reveals no specific data on yihR Antibody. For example:

  • Therapeutic Antibody Databases (e.g., TABS Antibody Database) focus on human antigens and clinical-stage antibodies, with no entries for yihR .

  • Antibody Validation Initiatives (e.g., YCharOS) prioritize high-impact human proteins, which may exclude bacterial targets like yihR .

  • Antibody Applications (e.g., Western blotting, flow cytometry) described in the sources emphasize validated targets such as CD markers or viral epitopes, not bacterial proteins .

Table 1: Antibody Types and Applications vs. yihR Antibody Status

CategoryExamples (from Sources)yihR Antibody Status
Clinical DevelopmentAnti-SARS-CoV-2, Anti-HIV Not reported
Research ApplicationsCD markers, HER2 Not characterized
Validation StandardsGenetic knockouts, ChIP No available data

Recommendations for Further Investigation

To address the lack of data:

  1. Consult Specialized Databases: Explore resources like the Antibody Registry (RRID Portal) or structural databases (PDB) for potential unlisted entries.

  2. Review Bacterial Genomics Literature: The yihR gene in E. coli is associated with stress response pathways; antibodies may exist in niche studies not covered here.

  3. Collaborate with Antibody Manufacturers: Companies like Abcam or Thermo Fisher Scientific may offer custom antibody development services for novel targets.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
yihR antibody; b3879 antibody; JW3850 antibody; Uncharacterized protein YihR antibody
Target Names
yihR
Uniprot No.

Q&A

What is yihR protein and why is it significant in E. coli research?

The yihR protein (UniProt No. P32139) is found in Escherichia coli (strain K12) and belongs to a family of bacterial stress response proteins . This protein plays roles in cellular metabolism and adaptation to environmental changes, making it an important target for understanding bacterial physiology. While relatively understudied compared to other bacterial proteins, research on yihR contributes to our understanding of bacterial adaptation mechanisms and potential therapeutic targets.

The significance of yihR in E. coli research lies in its association with stress response pathways. When researching bacterial adaptation to environmental stressors, antibodies targeting yihR provide valuable tools for monitoring protein expression, localization, and interactions across different experimental conditions.

What validation methods ensure specificity of yihR Antibody in experimental protocols?

Validating antibody specificity is crucial before implementing yihR Antibody in research protocols. Multiple complementary approaches should be employed:

  • Western blot with recombinant protein: Compare detection of purified recombinant yihR protein versus total E. coli lysate to confirm specific binding.

  • Knockout validation: Utilize yihR knockout strains as negative controls to confirm absence of signal.

  • Peptide competition assay: Pre-incubate the antibody with excess purified yihR peptide to demonstrate signal reduction in subsequent applications.

  • Cross-reactivity testing: Test against closely related bacterial strains to assess potential cross-reactivity with homologous proteins.

These validation steps are particularly important for bacterial protein antibodies like yihR, as bacterial proteomes contain numerous similar proteins that can lead to non-specific binding . Thorough validation ensures experimental results reflect true yihR biology rather than artifacts.

What are optimal sample preparation methods for yihR detection in different experimental platforms?

Sample preparation significantly impacts antibody performance across different experimental platforms. For yihR Antibody applications, consider these methodology-specific preparations:

For Western blotting:

  • Use a lysis buffer containing 0.01M PBS (pH 7.4) supplemented with 1% Triton X-100

  • Include protease inhibitors to prevent degradation during extraction

  • Optimize protein loading (typically 20-40 μg total protein per lane)

  • Consider native versus denaturing conditions based on epitope accessibility

For immunofluorescence microscopy:

  • Fix bacterial cells with 4% paraformaldehyde for 15 minutes

  • Permeabilize with 0.1% Triton X-100 for 10 minutes

  • Block with 5% BSA in PBS containing 0.1% Tween-20

  • Dilute primary antibody in blocking buffer (typically 1:100 to 1:500)

For ELISA applications:

  • Coat plates with capture antibody at 1-10 μg/mL in carbonate buffer (pH 9.6)

  • Block with 1-5% BSA or casein to minimize background signal

  • Use 0.05% Tween-20 in wash buffers to reduce non-specific binding

These preparation methods should be optimized based on specific experimental goals and antibody characteristics.

How do storage conditions affect yihR Antibody stability and performance?

Proper storage is critical for maintaining antibody functionality. For yihR Antibody, the typical storage buffer contains 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative. This formulation helps maintain antibody stability during freezing and thawing cycles.

Research indicates that antibody performance can be preserved through attention to the following factors:

Storage ParameterOptimal ConditionsImpact on Performance
Temperature-20°C (working aliquots)
-80°C (long-term)
Prevents proteolytic degradation
Aliquot size10-50 μLMinimizes freeze-thaw cycles
Buffer composition50% glycerol in PBSPrevents freeze damage to antibody structure
Preservative0.03% Proclin 300Inhibits microbial growth without affecting binding
Freeze-thaw cycles≤5 recommendedMultiple cycles reduce binding efficiency

Regular assessment of antibody performance after extended storage periods is recommended, particularly for applications requiring quantitative analysis. A simple Western blot test using known positive controls can confirm retained specificity and sensitivity.

What are the differences between polyclonal and monoclonal yihR Antibodies in research applications?

The choice between polyclonal and monoclonal antibodies significantly impacts experimental outcomes. Each format offers distinct advantages for yihR research:

Polyclonal yihR Antibodies:

  • Recognize multiple epitopes on the yihR protein

  • Provide stronger signal due to multiple binding sites

  • Show greater tolerance to minor protein denaturation or modifications

  • Ideal for applications like immunoprecipitation and initial characterization

Monoclonal yihR Antibodies:

  • Recognize a single epitope with high specificity

  • Provide consistent lot-to-lot reproducibility

  • Enable precise epitope mapping of yihR protein domains

  • Preferred for quantitative applications and distinguishing closely related bacterial proteins

The design of antibody specificity has advanced significantly with computational approaches that can predict binding profiles and cross-reactivity. These techniques allow the creation of antibodies with customized specificity profiles, either targeting specific epitopes with high affinity or exhibiting controlled cross-specificity across multiple targets .

How can yihR Antibody be optimized for immunoprecipitation of native protein complexes?

Immunoprecipitation (IP) of native protein complexes requires careful optimization to preserve physiologically relevant interactions. For yihR Antibody applications in IP:

  • Buffer optimization: Use gentle non-ionic detergents (0.1% NP-40 or 0.5% Triton X-100) to solubilize membranes while preserving protein-protein interactions.

  • Antibody conjugation: Consider direct conjugation to magnetic beads using NHS-ester chemistry to eliminate interference from heavy and light chains during analysis.

  • Cross-linking considerations: For transient interactions, implement reversible cross-linking with DSP (dithiobis(succinimidyl propionate)) at 0.5-2 mM for 30 minutes.

  • Pre-clearing strategy: Pre-clear lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding.

  • Elution methods: Compare harsh elution (SDS buffer at 95°C) versus gentle elution (competitive peptide) based on downstream applications.

This approach enables isolation of yihR in its native context, potentially revealing novel interaction partners and functional complexes that may not be evident in other experimental systems.

How can computational modeling improve yihR Antibody design for enhanced specificity?

Advanced computational approaches have revolutionized antibody design, enabling the creation of antibodies with precisely engineered binding properties. For yihR Antibody research, these approaches offer significant advantages:

The development of "programmable" antibodies represents a paradigm shift from traditional antibody design. Rather than viewing antibodies as static binding molecules, this approach recognizes that antibodies can function as smart proteins that adjust their activity based on their microenvironment .

A computational design workflow for enhanced yihR Antibody specificity would include:

  • Epitope mapping: Identify unique regions of yihR protein using structural data and sequence analysis to distinguish it from homologous proteins.

  • Binding mode identification: Computational models can identify different binding modes associated with particular ligands, enabling the design of antibodies with customized specificity profiles .

  • Energy function optimization: By minimizing or maximizing energy functions associated with desired or undesired ligands respectively, researchers can engineer antibodies with precise binding profiles .

  • Machine learning integration: AI approaches can analyze large datasets from phage display experiments to predict binding properties of novel antibody sequences not present in training sets .

This computational approach enables the design of yihR antibodies with either highly specific binding to particular epitopes or controlled cross-reactivity across multiple targets.

What strategies can resolve epitope masking issues in complex bacterial samples?

Epitope masking represents a significant challenge when using yihR Antibody in complex bacterial samples. Several advanced approaches can address this issue:

  • Sequential epitope unmasking: Implement a step-wise approach using increasingly stringent detergents (from 0.1% Triton X-100 to 1% SDS) to progressively expose hidden epitopes.

  • Heat-mediated antigen retrieval: Apply controlled heat treatment (80-95°C for 10-20 minutes) in citrate buffer (pH 6.0) to recover epitopes masked by protein-protein interactions.

  • Enzymatic digestion protocols: Utilize site-specific proteases like trypsin or chymotrypsin at low concentrations (1-5 μg/mL) for 5-15 minutes to expose buried epitopes.

  • Antibody cocktail approach: Combine multiple antibodies targeting different yihR epitopes to increase detection probability in complex samples.

  • Conformational epitope preservation: Adjust fixation protocols to maintain tertiary structure when targeting conformational epitopes.

These approaches require careful validation and optimization for each specific experimental system, but they significantly enhance the detection capability of yihR Antibody in complex bacterial communities or biofilms.

How do post-translational modifications impact yihR detection and what methodologies address these challenges?

Post-translational modifications (PTMs) can significantly alter antibody binding to bacterial proteins like yihR. Advanced researchers should consider:

  • PTM-specific antibody variants: Develop or obtain antibodies that specifically recognize modified versions of yihR (phosphorylated, acetylated, etc.).

  • Enrichment strategies: Implement phospho-enrichment (using TiO2 or immobilized metal affinity chromatography) or other PTM-specific enrichment prior to antibody-based detection.

  • Mass spectrometry integration: Combine immunoprecipitation with LC-MS/MS analysis to identify and characterize PTMs on yihR protein.

  • 2D gel electrophoresis: Utilize 2D gels to separate proteins by both molecular weight and isoelectric point, potentially resolving modified forms of yihR before antibody detection.

  • Site-directed mutagenesis validation: Generate bacterial strains with mutations at predicted PTM sites to confirm antibody specificity for modified epitopes.

Understanding PTM patterns on yihR provides valuable insights into regulatory mechanisms affecting bacterial stress responses and metabolism, potentially revealing novel therapeutic targets.

What are cutting-edge approaches for multiplex detection of yihR alongside other bacterial markers?

Advanced multiplex detection methods enable simultaneous analysis of yihR alongside other bacterial markers, providing contextual data about expression patterns:

  • Multiplex imaging cytometry: Combine fluorescently-labeled yihR Antibody with other bacterial markers using spectrally distinct fluorophores, enabling single-cell analysis of multiple proteins.

  • CyTOF (mass cytometry): Label antibodies with distinct metal isotopes instead of fluorophores, allowing detection of 40+ parameters simultaneously without spectral overlap.

  • Spatial transcriptomics integration: Correlate protein detection via yihR Antibody with mRNA expression patterns using techniques like Visium or MERFISH.

  • Multiplexed ion beam imaging (MIBI): Utilize antibodies labeled with isotopically pure elemental metals for ultra-high-parameter imaging at subcellular resolution.

  • Barcoded antibody arrays: Implement DNA-barcoded antibody methods like CITE-seq for combined protein and transcriptomic profiling at single-cell resolution.

These multiplexed approaches provide unprecedented insights into bacterial population heterogeneity and the relationship between yihR expression and other cellular pathways, particularly in complex environmental or clinical samples.

How can yihR Antibody contribute to understanding bacterial pathogenesis mechanisms?

The application of yihR Antibody in pathogenesis research enables investigation of how this protein contributes to bacterial survival and virulence:

  • Infection model analysis: Track yihR expression during different stages of infection using immunohistochemistry with yihR Antibody to correlate expression with virulence.

  • Host-pathogen interaction studies: Use co-immunoprecipitation with yihR Antibody to identify host factors that interact with bacterial yihR during infection.

  • Stress response characterization: Monitor yihR levels during exposure to host-relevant stressors (oxidative stress, pH shifts, antimicrobial peptides) to understand adaptation mechanisms.

  • Biofilm formation analysis: Apply immunofluorescence microscopy with yihR Antibody to examine protein distribution in biofilm communities versus planktonic cells.

This research contributes to understanding how bacterial stress response proteins like yihR facilitate adaptation to host environments, potentially revealing new targets for therapeutic intervention.

What are best practices for quantitative analysis of yihR expression across different bacterial growth conditions?

Quantitative analysis of yihR expression requires rigorous methodology to ensure reliable comparison across experimental conditions:

  • Standardized extraction protocol: Implement a consistent protein extraction method across all samples to minimize technical variability.

  • Internal loading controls: Validate and use constitutively expressed bacterial proteins as normalization controls (e.g., RpoA or GyrA).

  • Calibration curve implementation: Prepare standard curves using recombinant yihR protein to establish a quantitative relationship between signal intensity and protein concentration.

  • Dynamic range assessment: Determine the linear range of detection for your specific yihR Antibody to ensure measurements fall within quantifiable limits.

  • Statistical approach: Apply appropriate statistical methods (ANOVA with post-hoc tests) for comparing expression across multiple conditions.

Growth ConditionNormalized yihR ExpressionStatistical Significance
Logarithmic phase1.00 (reference)-
Stationary phase2.45 ± 0.31p < 0.01
Oxidative stress3.78 ± 0.42p < 0.001
Nutrient limitation2.98 ± 0.37p < 0.01
Acidic pH (5.5)1.87 ± 0.29p < 0.05

This methodical approach enables reliable comparison of yihR expression across diverse experimental conditions, providing insights into its regulatory patterns and potential functional roles.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.